Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 500,000 | reported | 01 Jul 2022 | tx 7+1,703,788 |
| Moderna, Inc. | 121,120 | reported | 30 Jun 2021 | tx 533+1,847,135−2,970,376 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 7,242 | reported | 28 May 2026 | tx 15+139,261−58,755 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 7,242 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | — | |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14,492 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 21,108 | — | |
| 15 Jun 2024 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 21,108 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | 0.00 USD | deriv |
| 04 Aug 2023 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15,810 | — | |
| 04 Aug 2023 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15,810 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 21,108 | 0.00 USD | deriv |
| 04 Nov 2022 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 12,205 | — | |
| 04 Nov 2022 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 12,205 | 0.00 USD | deriv |
| 04 Aug 2022 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15,810 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 500,000 | 0.00 USD | deriv |
| 19 Nov 2021 | PURCHASE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 17 | 8.88 USD | |
| 04 Nov 2021 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 12,205 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 379,788 | 0.00 USD | deriv |
| 30 Jun 2021 | SALE | Moderna, Inc. | 5,000 | 237.00 USD | |
| 30 Jun 2021 | EXERCISE | Moderna, Inc. | 5,000 | 25.93 USD | |
| 30 Jun 2021 | EXERCISE | Moderna, Inc. | 5,000 | 0.00 USD | deriv |
| 23 Jun 2021 | EXERCISE | Moderna, Inc. | 5,000 | 25.93 USD | |
| 23 Jun 2021 | SALE | Moderna, Inc. | 5,000 | 219.65 USD | |
| 23 Jun 2021 | EXERCISE | Moderna, Inc. | 5,000 | 0.00 USD | deriv |
| 16 Jun 2021 | EXERCISE | Moderna, Inc. | 5,000 | 25.93 USD | |
| 16 Jun 2021 | SALE | Moderna, Inc. | 5,000 | 200.00 USD |